ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia‐related changes and normal karyotype

Acute myeloid leukemia with myelodysplasia‐related changes (AML‐MRC) are poor outcome leukemias. Its diagnosis is based on clinical, cytogenetic, and cytomorphologic criteria, last criterion being sometimes difficult to assess. A high frequency of ASXL1 mutations have been described in this leukemia...

Descripción completa

Detalles Bibliográficos
Autores principales: Prats‐Martín, Concepción, Burillo‐Sanz, Sergio, Morales‐Camacho, Rosario M., Pérez‐López, Olga, Suito, Milagros, Vargas, Maria T., Caballero‐Velázquez, Teresa, Carrillo‐Cruz, Estrella, González, José, Bernal, Ricardo, Pérez‐Simón, José A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286456/
https://www.ncbi.nlm.nih.gov/pubmed/32216059
http://dx.doi.org/10.1002/cam4.2947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286456/
https://www.ncbi.nlm.nih.gov/pubmed/32216059
http://dx.doi.org/10.1002/cam4.2947

Ejemplares similares